Rigel Pharmaceuticals RIGL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $597K-0.7% | $601K-0.3% | $603K-0.7% | $607K+0.5% | $604K0.0% | ||
| $3.46M+25.8% | $2.75M-18.3% | $3.36M+2.7% | $3.28M-1.4% | $3.32M+59.3% | ||
| $2.73M-87.6% | $21.98M-8.5% | $24.03M-21.3% | $30.54M+3,520% | -$893K-106% | ||
| —— | $1.25M0.0% | $1.25M0.0% | $1.25M0.0% | $1.25M0.0% | ||
| -$7.98M+68.6% | -$25.36M+23.6% | -$33.18M-42.5% | -$23.28M-121% | -$10.55M— | ||
| $3.74M— | —— | —— | —— | $0— | ||
| $7.5M— | —— | —— | —— | $0— | ||
| -$10.92M— | —— | $4.27M+922% | $418K-13.6% | $484K— | ||
| -$16.17M-103% | -$7.95M-63.2% | -$4.87M— | —— | -$10.96M-317% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rigel Pharmaceuticals generate?
- Rigel Pharmaceuticals (RIGL) generated $79.3M in operating cash flow over the trailing twelve months.
- Where does Rigel Pharmaceuticals's cash flow data come from?
- Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
